Cargando…
The leptin sensitizer celastrol reduces age‐associated obesity and modulates behavioral rhythms
The prevalence of obesity increases with age in humans and in rodents. Age‐related obesity is characterized by leptin resistance and associated with heightened risk of metabolic disorders. However, the effect of leptin resistance per se has been difficult to disentangle from other effects of aging....
Autores principales: | Chellappa, Karthikeyani, Perron, Isaac J., Naidoo, Nirinjini, Baur, Joseph A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516176/ https://www.ncbi.nlm.nih.gov/pubmed/30821426 http://dx.doi.org/10.1111/acel.12874 |
Ejemplares similares
-
IL1R1 is required for celastrol’s leptin sensitization and anti-obesity effects
por: Feng, Xudong, et al.
Publicado: (2019) -
Creation of an Anti-Inflammatory, Leptin-Dependent Anti-Obesity Celastrol Mimic with Better Druggability
por: Zhou, Bo, et al.
Publicado: (2021) -
Perinatal Treatment with Leptin, but Not Celastrol, Protects from Metabolically Obese, Normal-Weight Phenotype in Rats
por: Reynés, Bàrbara, et al.
Publicado: (2022) -
Dietary challenges differentially affect activity and sleep/wake behavior in mus musculus: Isolating independent associations with diet/energy balance and body weight
por: Perron, Isaac J., et al.
Publicado: (2018) -
Age-Related Changes in Cellular Protective Pathways in Sleep Deprivation
por: Naidoo, Nirinjini
Publicado: (2020)